rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

India Pharma Inc

Subscribe via RSS
Rediff.com  »  News  »   India Pharma Inc

  News for India Pharma Inc

  • News
  • Business

India probes eye drop linked to vision loss in US

 A day after its plant was inspected by Indian drug regulatory bodies over allegations that its eye drop was linked to vision loss in the United States, Tamil Nadu-based Global Pharma Healthcare has......

Russian vaccine has efficacy of over 95%: RFID CEO

 The Russia-developed Sputnik V vaccine against coronavirus has been found to be over 95 percent effective, CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday.  ......

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

 Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots......

Serum's Covid vaccine, Covovax, recommended for approval

 An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's COVID-19 vaccine 'Covovax' with certain conditions,......

Twitter deliberately chose path of non-compliance: Prasad

 Information and Technology Minister Ravi Shankar Prasad on Wednesday said Twitter failed to comply with intermediary guidelines and has "deliberately" chosen the path of non-compliance despite......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

 The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

BSE 100 companies boost R&D, innovation challenges persist

 Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period......

India Inc capital expenditure story gets cement to semiconductor push

 Corporate India is starting to step up its capital expenditure plans amid government incentives and signs of rising demand, company executives and analysts have indicated. Illustration: Uttam......

India Inc feels the heat of West Asia conflict

 Industry execs nervous about rising freight cost, longer delivery time Illustration: Uttam Ghosh/Rediff.com Closely watched by the world for any escalation, the Iran-Israel conflict is already......

New drug policy, regulations slowing down pharma growth

 Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2025 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances